Pradofloxacin is a novel third-generation oral veterinary fluoroquinolone with activity against Gram-positive aerobic bacteria and anaerobes (lower minimum inhibitory concentrations in vitro). It also has activity against other bacterial species, including Bartonella henselae, Pasteurella multocida, Bordetella bronchiseptica, extra-intestinal Escherichia coli, and some mycobacterial species. This review focuses on the current knowledge of the mechanism of action, adverse effects, clinical applications, and pharmacokinetic/pharmacodynamic properties of pradofloxacin in cats. Copyright © 2014 Elsevier Ltd. All rights reserved.
Jane E Sykes, Joseph M Blondeau. Pradofloxacin: a novel veterinary fluoroquinolone for treatment of bacterial infections in cats. Veterinary journal (London, England : 1997). 2014 Aug;201(2):207-14
PMID: 24997792
View Full Text